FINAL EXAM
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
RADIO THERAPY
PAPER-II
RTH/J/20/41/II
Max. Marks:100
Important Instructions:
Attempt al questions in order.
Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer al the parts of a single question together.
Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. a) Molecular profiling of gliomas. 4+6
b) Management of glioblastoma multiforme.
6+4
b) Norton Simon hypothesis.
3. a) Mechanism of action of Nivolumab.
5+5
4. a) What do you understand with terms Oligoprogression and
4+6
Oligorecurrence?
b) Role of local therapies in oligo metastatic cancer.
4+6
compression (MESCC)?
b) Evidence based treatment of MESCC.
6. Enumerate the conditions where radiation therapy is used for benign 3+2+5
radiotherapy for Graves ophthalmopathy.
7. a) Pathological classification & staging of osteogenic sarcoma.
5+5
b) Extracorporeal radiation therapy in osteogenic sarcoma.
4
+ 3+3
b) Molecular profiling in soft tissue sarcoma.
c) Rhabdomyosarcoma: Risk grouping.
+3
b) Anti-emesis management in cancer.
c) Morphine.
10. a) Bevacizumab in colon cancer.
b) Drugs and dosage used in various types of Folfox regimens with
results.
************
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
NATIONAL BOARD OF EXAMINATIONS
JUNE 2020
RADIO THERAPY
PAPER-II
--- Content provided by FirstRanker.com ---
Time: 3 hoursRTH/J/20/41/II
Max. Marks:100
Important Instructions:
Attempt al questions in order.
--- Content provided by FirstRanker.com ---
Each question carries 10 marks.Read the question careful y and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer al the parts of a single question together.
--- Content provided by FirstRanker.com ---
Start the answer to a question on a fresh page or leave adequate space between two answers.Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. a) Molecular profiling of gliomas. 4+6
b) Management of glioblastoma multiforme.
--- Content provided by FirstRanker.com ---
2. a) Principles of cytotoxic chemotherapy.6+4
b) Norton Simon hypothesis.
3. a) Mechanism of action of Nivolumab.
5+5
--- Content provided by FirstRanker.com ---
b) Role of immunotherapy in melanoma.4. a) What do you understand with terms Oligoprogression and
4+6
Oligorecurrence?
b) Role of local therapies in oligo metastatic cancer.
--- Content provided by FirstRanker.com ---
5. a) What do you understand by metastatic epidural spinal cord4+6
compression (MESCC)?
b) Evidence based treatment of MESCC.
6. Enumerate the conditions where radiation therapy is used for benign 3+2+5
--- Content provided by FirstRanker.com ---
tumors. What are the likely long term complications? Describe in detail theradiotherapy for Graves ophthalmopathy.
7. a) Pathological classification & staging of osteogenic sarcoma.
5+5
b) Extracorporeal radiation therapy in osteogenic sarcoma.
--- Content provided by FirstRanker.com ---
8. a) Radiotherapy in plasmacystoma.4
+ 3+3
b) Molecular profiling in soft tissue sarcoma.
c) Rhabdomyosarcoma: Risk grouping.
--- Content provided by FirstRanker.com ---
9. a) Cancer related fatigue. 3 + 4+3
b) Anti-emesis management in cancer.
c) Morphine.
10. a) Bevacizumab in colon cancer.
--- Content provided by FirstRanker.com ---
5+5b) Drugs and dosage used in various types of Folfox regimens with
results.
************
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
--- Content provided by FirstRanker.com ---
EXAMINATION HALL.